Speakers

Speech Title : Decoupling Breast Density and Background Parenchymal Enhancement: Distinct Pathways for Bone and Vascular Risk Assessment

Graziella Di Grezia is a Tenure-Track Researcher at Link Campus University, Department of Life Sciences, Health, and Healthcare Professions, Rome, Italy. She is also an ASN Associate Professor (Seconda Fascia) and serves on the board of the Italian Society of Medical and Interventional Radiology (SIRM). She holds an MD with honors, a PhD in Pharmacological Sciences and Clinical and Experimental Medicine, a specialization in Radiodiagnostics, and a Master’s Degree in Breast Diagnostics and Interventional Surgery. Dr. Di Grezia has an extensive research portfolio, with over 100 publications indexed in PubMed and a Scopus h-index of 20. Her scientific expertise spans oncological and abdominal imaging, focusing on advanced techniques such as diffusion-weighted imaging (DWI), contrast-enhanced mammography, and artificial intelligence applications in diagnostic imaging. She is Principal Investigator in clinical research on DWI Breast MRI for dense breast tissue and actively participates in translational studies on gastrointestinal pathologies and tumor imaging. She contributes to the scientific community as a reviewer and editorial board member for multiple international journals, maintaining rigorous standards in scientific publication. Beyond medicine, Dr. Di Grezia is a classical pianist and artist, and founder of the Mail Poetry Project®, bridging creativity with scientific outreach.

Speech Title : Medical oncology Palliative medicine

Kunihiko Ishitani, MD, PhD President of Higashi Sapporo Hospital President of the International Research Society of the Sapporo Conference for Palliative and Supportive Care in Cancer (IRS-SCPSC) Kunihiko Ishitani is an MD, PhD with a specialization in medical oncology and palliative medicine. He studied biochemistry as a research fellow in the Department of Biochemistry at AECOM in the 1970s, and immunology as an assistant professor in the Department of Medical Oncology at Sapporo Medical College. In 1983, he established Higashi Sapporo Hospital (240 beds) as the first cancer palliative care hospital in Japan. From the outset, the physicians at Higashi Sapporo Hospital supported his vision and provided both palliative care and cancer treatment as needed. Higashi Sapporo Hospital now cares for approx. 20% of the cancer deaths in Sapporo City (population 1.97 million) each year. At his request, Higashi Sapporo Hospital established a sister-hospital arrangement with Calvary Hospital in New York in 1990, and have been involved in the ongoing exchange of staff. In 1993, Higashi Sapporo Hospital, Calvary Hospital, and MSKCC jointly held the “Hawaii Conference; Cancer Care in the 1990’s Supportive Care Issues”. Based on that experience, he launched the first Japanese Society of Palliative Medicine in Sapporo City in 1996. Since then, he has gone on to organize many palliative care-related conferences in Japan. He organized the first Sapporo Conference for Palliative and Supportive Care in Cancer (SCPSC) in 2014 and assumed the position of president of the IRS-SCPSC. Since then, SCPSC has been held every three years to promote the scientific advancement of palliative oncology and psycho-oncology, with a focus on providing lectures by world experts in each field. Each conference has attracted over 1,000 people from over 20 countries. The fifth conference is scheduled for 2026 under an innovative program. Dr. Ishitani also served as Associate Editor of the BMJSPCare from 2018 to 2021 and as Asian Editor from 2022 to 2024.

Speech Title : updated soon

Christopher P. Adams is a visionary entrepreneur and innovator in the biotech and life sciences sector, currently serving as the Founder and CEO of Andarix, a clinical-stage company specializing in targeted radiolabeled therapeutics for cancer treatment. With a proven track record of founding and co-founding multiple life science and technology-based companies in Massachusetts, Mr. Adams has consistently demonstrated his ability to identify unmet medical needs and develop innovative solutions. His contributions span diverse areas, including obesity therapeutics, eye disease detection software, and genomics technology for colon cancer detection. Notably, he developed a cornea wound treatment technology that has become the current standard of care.